Updated hourlyHourly refreshWed, Oct 28, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance · Automotive
New York, New York--(August 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR), including those who bought Avis common stock to cover a short position, between February 20, 2025 and April 21, 2026, inclusive (the "Class Period"), of the important September 29, 2026 lead plaintiff deadline.SO WHAT: If you purchased Avis securities during the Class Period you may be entitled to compensation...
Aug 20 · 02:17·Newsfile
Finance · Automotive
Kitchener, Ontario--(August 19, 2026) - Alchemy Labs Inc. (TSXV: ALCH) ("Alchemy" or the "Company"), a Canadian nanotechnology company developing advanced protective solutions for the automotive and defence industries, today reported financial results for the three months ended June 30, 2026. All amounts are reported in Canadian dollars unless otherwise noted. Business Highlights (Three Months Ended June 30, 2026):Improved automotive product availability, supporting a return...
Aug 19 · 21:56·Newsfile
Finance · Automotive
New York, New York and New Orleans, Louisiana--(August 19, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Avis Budget Group, Inc. ("Avis" or the "Company") (NASDAQ: CAR) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors who purchased or otherwise acquired Avis securities (including those who bought Avis common stock to cover a...
Aug 19 · 20:31·Newsfile
Finance · Automotive
CAMPBELL, Calif., August 19, 2026--ChargePoint Holdings, Inc. (NYSE: CHPT) ("ChargePoint" or the "Company"), a leading provider of EV charging solutions, today announced it will release financial results for the second quarter of fiscal year 2027, which ended July 31, 2026, on September 2, 2026. ChargePoint will host a conference call to review the Company’s financial results at 1:30 p.m.
Aug 19 · 20:15·Business Wire
Automotive
Liberty County, Florida--(August 19, 2026) - Drive Wise Innovations has completed the rollout of 37 new electric vehicle chargers across Florida, adding more charging options for drivers and expanding the company's presence in the state's growing EV market.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8111/309886_c7a3ad9f64bfbb15_001full.jpgThe new chargers are now installed and operational. The project was carried out after...
Aug 19 · 19:40·Newsfile
Automotive
The award recognizes the companies for measured success in technology implementation and builds on a previous Brandon Hall Group™ award honoring innovation in talent mobility DENVER, Aug. 19, 2026 -- NBCUniversal (NBCU), in partnership with longtime global mobility partner...
Aug 19 · 17:43·PR Newswire
Automotive
ARLINGTON, Va., August 19, 2026--JEDEC Solid State Technology Association, the global leader in the development of standards for the microelectronics industry, today announced that it is hosting an Automotive Electronics Forum on September 17, 2026 in Santa Clara, CA. Advance registration is required and space is limited. For more information and registration, visit the JEDEC website.
Aug 19 · 17:00·Business Wire
Automotive · Sports
What happens when you combine the split-second intensity of a NASCAR® pit stop with the quick wit of one of YouTube’s most recognizable creators? You get PIT STOP TONIGHT – TOYOTA RACING’s new four-episode YouTube series that trades traditional driver interviews for fast-paced entertainment designed […]
The post Meet the Drivers Behind the Helmets in <em>TOYOTA RACING’s PIT STOP TONIGHT</em> appeared first on Toyota USA Newsroom.
Aug 19 · 13:58·Toyota
Finance · Healthcare
HONG KONG, August 19, 2026 - Hengrui Pharma (“Hengrui” or “the Company”) today announced its financial results for the first half of 2026. During the reporting period, innovative drugs remained the Company’s key growth driver, while globalization initiatives continued to validate the global value of Hengrui’s innovation portfolio.
Financial Highlights
In the first half of 2026, Hengrui reported revenue of RMB15.46 billion. Drug sales revenue was RMB13.95 billion, representing a year-over-year increase of 1.87%. Innovative drug sales increased by 16.38% year-over-year and accounted for 63.16% of total drug sales, with non-oncology innovative drug sales increasing by 73.97% year-over-year and emerging as an increasingly important growth driver.
Net profit attributable to shareholders of the listed company was RMB4.47 billion, up 0.34%. R&D investment totaled RMB4.61 billion, representing 29.8% of revenue.
Pipeline and Regulatory Highlights
Hengrui continued to advance its pipeline in China during the reporting period, obtaining seven innovation-related approvals, including two Class 1 innovative medicines, one Class 2 innovative medicine and four additional indications. At the end of the reporting period, nine marketing applications had been accepted for review by China’s National Medical Products Administration, while 17 clinical programs had advanced to Phase III, 22 to Phase II, and 10 innovative assets had entered Phase I clinical development.
Hengrui also reported progress across its metabolic pipeline. Two Phase III studies of ribupatide injection, a GLP-1/GIP dual receptor agonist, in China for type 2 diabetes reported positive topline results, supporting a planned NDA submission. HRS-7535, an oral small molecule GLP-1 receptor agonist, met all primary and key secondary endpoints at Week 44 in a China Phase III obesity study, with continued weight loss through Week 50 and mean body-weight reduction of up to 11.1%. An NDA submission is planned.
Global Partnerships and Business Development
Hengrui continued to advance its globalization strategy through diversified collaboration models. Since 2023, the Company has completed 13 overseas business development transactions, including out-licensing, NewCo and strategic alliances, with a total potential transaction value of approximately US$42 billion. These collaborations include leading global pharmaceutical companies such as BMS, GSK and others.
Among the diversified collaboration models Hengrui has explored, NewCo has also seen important progress in 2026. Kailera Therapeutics completed its Nasdaq IPO in April 2026, becoming one of the largest biotech IPOs at the time. Braveheart Bio also successfully listed on the Nasdaq Global Market on August 6, 2026.
Scientific Recognition
During the reporting period, 204 research findings related to Hengrui products were published in academic journals and received international recognition. Hengrui participated in the American Society of Clinical Oncology Annual Meeting for the 16th consecutive year, with 91 studies accepted, including 11 oral presentations—a new high for the Company. Research in non-oncology areas was also presented at major international congresses, including the American Diabetes Association, International Stroke Conference, World Congress of Nephrology, American College of Cardiology, American Academy of Dermatology, and European Alliance of Associations for Rheumatology.
Outlook
Looking ahead, Hengrui will continue to advance its innovation and globalization strategy, while further pursuing its dual-growth strategy across oncology and chronic diseases. The Company will strengthen its global R&D capabilities, pursue diversified international collaboration models, and continue to focus on delivering sustainable long-term value and bringing more high-quality innovative therapies to patients worldwide.
Aug 19 · 12:43·ACN Newswire
Automotive · Industrial
The August 26 grand opening brings local R&D, advanced manufacturing, and supply chain capabilities directly to regional OEM partners. ATLANTA, Aug. 19, 2026 -- YFORE, a global Tier 1 automotive electronics supplier specializing in intelligent mobility, will celebrate the...
Aug 19 · 12:14·PR Newswire
Energy · Automotive
New shop offers a fast, stay-in-your-car oil change for local drivers
New shop offers a fast, stay-in-your-car oil change for local drivers
Aug 19 · 12:02·GlobeNewswire
Automotive
INCLINE VILLAGE, Nev., August 19, 2026--Kerrigan Advisors, the leading exclusive sell-side advisor and thought partner to auto dealers nationwide, represented Car Pros Automotive Group, a leading Southern California dealership group, in the sale of Car Pros Kia Huntington Beach to Sutherlin Automotive Group, which recently acquired the Subaru and Volkswagen franchises in the market and also owns dealerships in Tennessee and Alabama. Car Pros Kia Huntington Beach ranked as the #1 Kia dealer in Or
Aug 19 · 12:00·Business Wire